Unibest

Pharmaceutical intermediates

Tovorafenib Intermediates

3 pharmaceutical intermediates for Tovorafenib. Indication: Glioma.

提交项目All intermediates

About Tovorafenib

Originator
Sunesis Pharmaceuticals Inc
Indication
Glioma
Approved Date
04/23/2024
NCE Patent
04/23/2029
DS/DP
08/04/2031

Available intermediates

3 intermediates currently listed for Tovorafenib. Request specifications, documentation or a quotation for any item below.

Tovorafenib intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
4-Chloro-alpha,alpha,alpha-trifluoro-m-toluidine320-51-4//
6-aMino-5-chloropyriMidine-4-carboxylic acid914916-98-6//
2-acetylthiazole-5-carboxylic acid1095824-76-2//

Other programs under T

Tazemetostat HydrobromideTazobactam SodiumTegoprazanTenapanor HydrochlorideTeneligliptinTetrabenazineTezacaftorTianeptine sodium salt

Building toward Tovorafenib?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →